[Clinical pathology, diagnosis, and treatment of mixed growth hormone-and prolactin cell adenoma]
Related Experiment Video
Updated: Aug 17, 2026
Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
Ming-dong Wang1, Wen-bin Ma, Mei Guo
1Department of Neurosurgery, PUMC Hospital, CAMS and PUMC, Beijing 100730, China.
Objective:
To discuss the clinical pathology and management of mixed growth hormone- and prolactin (GH-PRL) cell adenoma.
Method:
Eight patients (4 men and 4 women, with the mean age of 32.3 year old and duration of symptoms 12 months) underwent examination of serum endocrine and magnetic resonance imaging. Clinical manifestations included headache, physiognomy of acromegalic patient, large pudgy hands and foots, menstrual dysfunction, amenorrhea, galactorrhea, and descending vision. Patients underwent transsphenoidal microsurgery of mixed GH-PRL pituitary adenoma between 1986 and 2004.
Results:
The hypersecretion of GH and PRL was relieved after operation. Headache was obviously improved in all patients. In 5 cases the menstrual dysfunction and amenorrhea were recovered. In 4 cases the galactorrhea and descending vision disappeared.
Conclusions:
The diagnosis of mixed GH-PRL pituitary adenoma can be made according to the results examination of serum endocrine, pathology and clinical manifestations. Its endocrine features are related to the invasion extent of the adenoma. The transsphenoidal approach is the preferred treatment for mixed GH-PRL pituitary adenoma.
